WNBA Eliminates Marijuana Testing in Landmark 7-Year CBA Deal
Advertisement
In a move that signals a seismic shift in how professional sports leagues view cannabis, the Women's National Basketball Association has officially ended marijuana testing for its players. The elimination of cannabis-related drug testing was included as part of the WNBA's new seven-year collective bargaining agreement, which players unanimously approved on March 23, 2026, with more than 90 percent participating in the ratification vote over the weekend.
The deal, which runs through the 2032 season, represents one of the most significant labor agreements in women's professional sports history — and its inclusion of cannabis reform underscores a broader cultural reckoning happening across the athletic world.
Key Takeaways
- The WNBA unanimously approved a new 7-year CBA that completely eliminates marijuana testing for players, effective immediately through the 2032 season.
- The decision follows similar reforms across the NFL, MLB, NHL, and NCAA, but goes further by removing testing entirely rather than just reducing penalties.
- Cannabis policy reform in professional sports reflects the broader national shift toward legalization, with 24 states plus D.C. now permitting recreational use.
Table of Contents
- What the New CBA Actually Says About Cannabis
- A Growing Trend Across Professional Sports
- Why This Matters Beyond the Basketball Court
- Player Reactions and Advocacy
- The Broader Workplace Implications
- What Comes Next for Cannabis in Sports
What the New CBA Actually Says About Cannabis
The elimination of marijuana testing was listed among 37 potential compromises in a WNBA CBA proposal summary shared during negotiations between the league and the WNBA Players Association. The item, described simply as "Elimination of Marijuana Testing," removes cannabis from the league's prohibited substance testing protocols.
Under the previous CBA, marijuana remained a prohibited substance for WNBA players, who were subject to testing for THC metabolites. While first-time offenses generally resulted in treatment referrals rather than immediate suspensions, repeated violations could escalate to fines and game suspensions — penalties that players and advocates argued were disproportionate and outdated.
The new agreement effectively acknowledges what many players, coaches, and medical professionals have argued for years: cannabis should not be treated as a performance-enhancing drug or a substance warranting punitive workplace testing in professional athletics.
A Growing Trend Across Professional Sports
The WNBA's decision does not exist in isolation. It follows a wave of cannabis policy reforms across virtually every major North American professional sports league over the past several years.
The National Football League stopped suspending players for positive marijuana tests in 2020, as part of its own collective bargaining negotiations. The league now only tests during a limited two-week window during training camp, and players who test positive are referred to treatment programs rather than facing immediate discipline.
Major League Baseball removed cannabis from its list of banned substances in 2019, following the tragic death of pitcher Tyler Skaggs. The National Hockey League has never included marijuana on its banned substance list, though it does test for THC and refers players to treatment if levels exceed certain thresholds.
The National Basketball Association — the WNBA's counterpart league — suspended random marijuana testing during the COVID-19 pandemic in 2020 and has since maintained a relaxed approach to cannabis enforcement, though it has not formally removed cannabis from its drug testing program.
The NCAA also softened its approach in 2024, raising its THC threshold and reducing penalties for positive tests among college athletes.
What makes the WNBA's move particularly noteworthy is the totality of the change. Rather than raising thresholds or reducing penalties, the league has eliminated marijuana testing entirely — a clean break from decades of prohibition-era drug policy in professional sports.
Why This Matters Beyond the Basketball Court
The WNBA's decision carries implications that extend well beyond the hardwood. Professional sports leagues serve as cultural bellwethers, and their policies around cannabis have historically reinforced the stigma associated with marijuana use.
For decades, athletes who used cannabis — whether for pain management, recovery, stress relief, or recreation — faced career-threatening consequences. The threat of a positive drug test forced many to choose between a natural remedy and their livelihood, pushing some toward more dangerous alternatives like opioid painkillers or alcohol.
Research has increasingly supported the notion that cannabis can play a legitimate role in athletic recovery. A growing body of evidence suggests that cannabinoids like CBD may help reduce inflammation, manage chronic pain, improve sleep quality, and support mental health — all critical concerns for elite athletes whose bodies endure extraordinary physical stress.
The WNBA's decision also arrives at a time when the broader legal landscape around cannabis is rapidly evolving. As of March 2026, 24 states plus the District of Columbia have legalized recreational marijuana, and 38 states have some form of medical cannabis program. Federal rescheduling of cannabis from Schedule I to Schedule III [Quick Definition: A mid-level federal drug classification including ketamine and testosterone] is actively under consideration, a process that would further legitimize the plant's medical applications.
By removing cannabis testing, the WNBA is aligning its workplace policies with the legal and cultural reality experienced by the majority of Americans — a move that advocacy groups have praised as both practical and overdue.
Player Reactions and Advocacy
The cannabis testing elimination was one of many progressive provisions in the new CBA, which also addressed salary increases, improved housing provisions, enhanced parental leave benefits, and better travel accommodations. Players overwhelmingly celebrated the comprehensive nature of the deal.
The WNBA Players Association had been vocal in its advocacy for cannabis policy reform during negotiations, framing the issue not just as a matter of personal freedom but as one of health, safety, and equity. Many players pointed out the racial disparities in cannabis enforcement — both within sports and in society at large — as a key motivation for seeking change.
Cannabis advocacy organizations, including NORML and the Marijuana Policy Project, praised the WNBA's decision as a model for other leagues and workplaces. The move was characterized as a recognition that cannabis testing in professional sports has always been more about optics and control than about player health or competitive fairness.
The Broader Workplace Implications
The WNBA's elimination of marijuana testing reflects a larger national conversation about cannabis and workplace drug testing. Across the United States, employers in both the public and private sectors are rethinking their approach to cannabis screening.
Several states, including California, New York, New Jersey, and Washington, have enacted laws prohibiting employers from taking adverse action against employees or job applicants based solely on positive cannabis tests. These laws recognize that a positive THC test reflects past use — potentially days or weeks prior — rather than current impairment.
The federal government's own trajectory on cannabis rescheduling [Quick Definition: The federal process of moving cannabis from Schedule I to a less restrictive category] further complicates the traditional justification for workplace testing. If cannabis is reclassified as a Schedule III substance, employers will face mounting pressure to treat it more like other legal substances, including alcohol and prescription medications.
For the cannabis industry, the WNBA's decision represents another brick in the wall of normalization. Each major institution that moves away from punitive cannabis policies helps erode the stigma that has long been the primary barrier to broader acceptance and reform.
What Comes Next for Cannabis in Sports
The WNBA's new CBA sets a precedent that will likely influence negotiations in other professional leagues. The NBA's own collective bargaining agreement is expected to undergo review in coming years, and the WNBA's outright elimination of testing could provide a template.
International sports bodies, including the World Anti-Doping Agency, have also been reconsidering their approach to cannabis. WADA raised the threshold for positive THC tests in 2021 and has faced ongoing pressure from athlete advocacy groups to remove cannabis from its prohibited list entirely.
The direction of travel is clear. As public opinion continues to shift, as legal frameworks continue to evolve, and as scientific understanding of cannabis continues to deepen, the days of punitive marijuana testing in professional sports appear to be numbered.
The WNBA, by acting decisively and unanimously, has positioned itself at the forefront of this change — proving once again that progress in sports policy often starts with the athletes who demand it.
Pull-Quote Suggestions:
"Major League Baseball removed cannabis from its list of banned substances in 2019, following the tragic death of pitcher Tyler Skaggs."
"The National Hockey League has never included marijuana on its banned substance list, though it does test for THC and refers players to treatment if levels exceed certain thresholds."
"Rather than raising thresholds or reducing penalties, the league has eliminated marijuana testing entirely — a clean break from decades of prohibition-era drug policy in professional sports."
Why It Matters: The WNBA unanimously approved a historic CBA that eliminates marijuana testing for players. Here's what this means for cannabis policy in professional sports.